凯莱英 (002821)
Asymchem Laboratories (Tianjin) Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 36059.37
- Circulating A-Shares(W): 31699.99
- Earnings Per Share(RMB): 2.1800
- Net Assets Per Share(RMB): 48.1160
- Operating Revenue(W RMB): 462987.71
- Total Profit(W RMB): 90994.91
- Net Profit Attributable to Parent(W RMB): 80024.52
- Net Profit Growth Rate(%): 12.66
- Weighted Return on Equity(%): 4.63
- Operating Cash Flow Per Share(RMB): 3.1730
- Undistributed Profit Per Share(RMB): 23.5256
- Capital Reserve Per Share(RMB): 24.1053
2. Main Business
The main business covers:
- Providing a full life-cycle one-stop service for domestic and foreign pharmaceutical companies and biotechnology companies.
3. Company Basic Information
- Company Name: Asymchem Laboratories (Tianjin) Co., Ltd.
- Listing Date: 2016-11-18
- Industry: Pharmaceutical Manufacturing
- Address: No. 71, 7th Avenue, Tianjin Economic-Technological Development Area, Tianjin, China
- Website: www.asymchem.com.cn
- Company Profile: The company was established through the overall change of Asymchem Laboratories (Tianjin) Co., Ltd. It provides a full life-cycle one-stop service for domestic and foreign pharmaceutical companies and biotechnology companies.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | ASYMCHEM LABORATORIES, INCORPORATED | General Legal Person | 11513.32 | 36.32 |
| 2 | China Europe Healthcare Hybrid Securities Investment Fund A | Fund | 1631.90 | 5.15 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1328.77 | 4.19 |
| 4 | Tianjin Guorong Business Information Consulting Co., Ltd. | General Legal Person | 637.66 | 2.01 |
| 5 | Huabao CSI Healthcare ETF | Fund | 564.67 | 1.78 |
| 6 | China Europe Healthcare Innovation Equity Securities Investment Fund A | Fund | 487.80 | 1.54 |
| 7 | Asymchem Laboratories (Tianjin) Co., Ltd. - 2022 Employee Stock Ownership Plan | General Legal Person | 318.28 | 1.00 |
| 8 | China Merchants CSI Bio-medicine Index Securities Investment Fund (LOF) A | Fund | 293.60 | 0.93 |
| 9 | Tianhong Pharmaceutical Innovation Hybrid Securities Investment Fund A | Fund | 90.28 | 0.28 |
| 10 | China Merchants Healthcare Industry Equity Securities Investment Fund | Fund | 70.53 | 0.22 |
5. Concept Sectors
- H-Share
- CXO Concept
- Innovative Drug
- Weight Loss Drug
- Synthetic Biology
- Margin Trading & Securities Lending
- High-Performance Stock
- Fund Heavy Holdings
- MSCI Mid Cap
- Overseas Business
- Fund Reducing Holdings
- Non-Cyclical Stock
- SME 100
- Mid Cap Growth
- SZSE 300
- Technology 100
- SZSE Growth
- SME 300
- SZSE Innovation
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information